HCA Healthcare Inc. (NYSE:HCA)

A consistent upward trajectory in profitability is observed from 2017 through 2021, characterized by a period of steady growth followed by a substantial surge in the final fiscal year. The growth is evident across all reported profit levels, from EBITDA down to net income, indicating a strengthening of the overall financial position.

EBITDA Growth Trends

Earnings before interest, tax, depreciation and amortization exhibited continuous growth over the five-year period. From 2017 to 2020, EBITDA increased from US$ 8,202 million to US$ 9,735 million, reflecting a steady moderate expansion. A significant acceleration occurred in 2021, with EBITDA rising to US$ 14,252 million, representing a year-over-year increase of approximately 46%.

Operational Profitability and EBIT

Earnings before interest and tax (EBIT) followed a similar pattern of initial growth followed by stabilization. After rising from US$ 6,071 million in 2017 to US$ 7,090 million in 2018, EBIT remained relatively flat through 2020, fluctuating minimally around the US$ 7,000 million mark. This stagnation was broken in 2021, when EBIT surged to US$ 11,399 million, aligning with the broader increase in EBITDA.

Net Income and Bottom-Line Performance

Net income attributable to the company demonstrated the highest relative volatility. While it grew significantly between 2017 and 2018, it experienced a slight dip in 2019 before recovering and eventually spiking to US$ 6,956 million in 2021. This indicates that while operational cash flow (EBITDA) remained stable or grew, the final net profit was more susceptible to non-operational factors during the 2018-2020 period.

Analysis of Profitability Gaps

The variance between EBITDA and EBIT reveals a widening gap over time, suggesting an increase in depreciation and amortization expenses. Furthermore, the gap between EBIT and Net Income expanded significantly by 2021, though the overall efficiency of converting operational earnings into net profit improved substantially in the final year of the analysis.

Between 2017 and 2021, a consistent increase in both Enterprise Value (EV) and Earnings before interest, tax, depreciation and amortization (EBITDA) was observed, although the relationship between these two metrics shifted significantly in the final year of the period.

Enterprise Value Trends

The Enterprise Value exhibited a continuous upward trajectory, rising from 69,421 million USD in 2017 to 109,659 million USD in 2021. The growth was steady through 2020, followed by a substantial increase of approximately 19.4% between 2020 and 2021.

EBITDA Performance

Operational earnings grew incrementally from 8,202 million USD in 2017 to 9,735 million USD in 2020. A sharp acceleration occurred in 2021, with EBITDA increasing to 14,252 million USD, reflecting a significant expansion in earnings capacity during the final year.

EV/EBITDA Ratio Dynamics

The EV/EBITDA ratio experienced a gradual increase from 8.46 in 2017 to a peak of 9.43 in 2020, indicating that the enterprise valuation was growing at a faster rate than operational earnings during this window. However, in 2021, the ratio contracted to 7.69, the lowest point in the five-year sequence. This decline demonstrates that the surge in EBITDA growth in 2021 significantly outpaced the growth in Enterprise Value, resulting in a lower valuation multiple relative to the company's earnings power.